GDF15 in Anorexia Nervosa

Evaluating plasma levels of a protein called GDF15 in active and recovered anorexia nervosa, as well as healthy controls

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anorexia Nervosa Feeding and Eating Disorders Mental Disorders

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Karolinska Institutet

Stockholm, 11624, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

active DSMV diagnosis of anorexia nervosa/ at least two years of recovery from DSMV anorexia nervosa / no history of anorexia nervosa

Exclusion criteria

male

Treatment and study plan

Primary outcomes

plasma GDF15

Time frame: At baseline

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Registry information

Official study title

Elevated Plasma GDF15 Combined With FGF21 Suggests Mitochondrial Dysfunction in a Subgroup of Anorexia Nervosa Patients

Important dates

Study start: 2017
Primary completion: 2021
Study completion: 2024
First posted: Jun 11, 2025
Registry last updated: Jun 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed